Antibodies against SARS-CoV-2 in cerebrospinal fluid: Clinical features and laboratory findings of hospitalized patients with neurologic symptoms in the pandemic era
Anti-SARS-CoV-2 antibodies in CSF seem to be related to a past immunization or a pre-existing cross reactive immunity and passive diffusion through a disrupted blood-brain-barrier, but not to an intrathecal antibody synthesis.
Authors
- Dilek Ataklı (ORCID: https://orcid.org/0000-0001-6458-8374)
- Sezin Alpaydın Baslo (ORCID: https://orcid.org/0000-0002-4096-3552)
- Burcu Yüksel (ORCID: https://orcid.org/0000-0003-3976-5564)
- Eda Salihoglu Kara (ORCID: https://orcid.org/0000-0001-8756-7322)
- Aysun Soysal (ORCID: https://orcid.org/0000-0002-1598-5944)
- Serap Ruken Teker (ORCID: https://orcid.org/0000-0001-6825-8380)
- Mesrure Köseoğlu (ORCID: https://orcid.org/0000-0003-0469-0064)
- Fatma Betül Öktelik (ORCID: https://orcid.org/0000-0002-7994-5618)
- Günnur Deniz (ORCID: https://orcid.org/0000-0002-0721-6213)
- Aysu Şen (ORCID: https://orcid.org/0000-0002-6192-4552)
- Araz Ceren Incesoy (ORCID: https://orcid.org/0000-0002-4865-1481)
- Begum Cengizler (ORCID: https://orcid.org/0000-0002-4341-5295)
Institutions
- Bakırköy Psychiatric Hospital (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Istanbul University (TR)
Publication Details
- Journal
- Ideggyógyászati Szemle
- Published
- 2025-01-01
- DOI
- https://doi.org/10.18071/isz.77.0136
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00